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Mitochondrial Genome Linearization Is a Causative
Factor for Cardiomyopathy in Mice and Drosophila
Yun Chen, Megan Sparks, Poonam Bhandari, Scot J. Matkovich, and Gerald W. Dorn II
Abstract
Aims:Mitofusin (Mfn)2 redundantly promotes mitochondrial outer membrane tethering and organelle fusion with
Mfn1, and uniquely functions as the mitochondrial receptor for Parkin during PTEN-induced putative kinase 1
(PINK1)-Parkin-mediated mitophagy. Selective deletion of Mfn2 with retention of Mfn1 preserves mitochondrial
fusion while rendering damaged mitochondria resistant to normal quality control culling mechanisms. Conse-
quently, neuron and cardiomyocyte-specific Mfn2 gene ablation is associated with accumulation of damaged
mitochondria and organ dysfunction. Here, we determined how mitochondrial DNA (mtDNA) damage contrib-
utes to cardiomyopathy in Mfn2-deficient hearts. Results: RNA sequencing of Mfn2-deficient hearts revealed
increased expression of some nuclear-encoded mitochondrial genes, but mitochondrial-encoded transcripts were
not upregulated in parallel and mtDNA content was decreased. Ultra-deep sequencing of mtDNA showed no
increase in single nucleotide mutations, but copy number variations representing insertion–deletion (in–del)
mutations were induced over time by cardiomyocyte-specific Mfn2 deficiency. Double-strand mtDNA breaks in
the form of in–dels were confirmed by polymerase chain reaction, and in the form of linear mitochondrial genomes
were identified by southern blot analysis. Linearization of Drosophila cardiomyocyte mtDNA using conditional
cardiomyocyte-specific expression of mitochondrial targeted XhoI recapitulated the cardiomyopathy of Mfn2-
deficient mouse hearts. Innovation: This is the first description of mitochondrial genome linearization as a caus-
ative factor in cardiomyopathy. Conclusion: One of the consequences of interrupting mitochondrial culling by the
PINK1-Mfn2-Parkin mechanism is an increase in mtDNA double-stranded breaks, which adversely impact mi-
tochondrial function and DNA replication. Antioxid. Redox Signal. 21, 1949–1959.
Introduction
Mitochondrial dynamics encompasses organelle mo-tility, fission, and fusion. Subcellular mitochondrial
transport and remodeling of highly interconnected mito-
chondrial networks through fusion and fission reactions is
observed in most cell types (39). Fragmentation of these mi-
tochondrial networks through organelle fission and network
regeneration via organelle fusion are necessary to distribute
mitochondria to daughter cells during cell mitosis (5). Because
cardiomyocyte mitochondria exist as tightly packed and im-
mobile organelles rather than as an interconnected network,
and since adult cardiomyocytes have exited the mitotic cycle,
these cells do not exhibit the typical requirement for mito-
chondrial dynamism. Indeed, despite having the largest
proportion of mitochondria (*30% by volume) of any cell
type, mitochondrial fusion has not been directly observed in
adult cardiomyocytes (15). Nevertheless, cardiomyocytes ex-
press mitochondrial fusion and fission proteins in abundance,
suggesting that there may be noncanonical functions for mi-
tochondrial dynamics factors in this cell type.
In adult hearts, interruption of cardiomyocyte mitochon-
drial fusion by conditional combined genetic ablation of mi-
tofusins (Mfn)1 and 2 not only induces mitochondrial
fragmentation from unopposed mitochondrial fission, but
provokes massive accumulation of abnormal mitochondria
(12). Individual deletion of Mfn1 or Mfn2 in cardiac myocytes
avoids mitochondrial fragmentation because these two pro-
teins are functionally redundant fusion factors (15, 16).
Nevertheless, cardiomyocyte Mfn2 deletion (but not Mfn1
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deletion) provoked development of unusually large dys-
morphic mitochondria, cardiomyocyte respiratory dysfunc-
tion, and progressive cardiomyopathy (9). The mechanistic
basis by which Mfn2 (but not Mfn1) deficiency evokes accu-
mulation of abnormal mitochondria was revealed through its
selective ablation in mouse livers, hearts, and neurons (9, 26,
31, 33). Together, these studies describe a central role forMfn2
in mitochondrial quality control as the essential transduction
factor mediating signaling from the mitochondrial PTEN-
induced putative kinase 1 (PINK1) to the cytosolic E3 ubiquitin
ligase Parkin. Given that mitochondrial fusion is preserved
when only one Mfn is ablated and the other is retained, the
uniquely deleterious effects of Mfn2 ablation on mitochon-
drial structure and function appear to be explained by inter-
ruption of Parkin-mediated mitophagy.
Among the many potential molecular casualties of defec-
tive mitochondrial quality control is DNA of mitochondrial
genomes (mitochondrial DNA [mtDNA]). Mitochondria
possess *16.6 kb circular genomes encoding 13 genes of the
respiratory chain, plus essential ribosomal and transfer RNAs
(tRNAs). Increased mtDNA point mutations and insertion–
deletions (in–dels) have been implicated in skeletal myopathy
caused by combined ablation of Mfn1 and Mfn2 (8), but in
view of the recent identification of an essential function for
Mfn2 in mitophagic mitochondrial culling it is unclear whe-
ther mtDNA damage occurred as a consequence of defective
mitochondrial fusion or interruption of mitophagy. Accord-
ingly, we interrogatedmitochondrial genomes before and after
appearance of the cardiomyopathy induced by cardiomyocyte-
specific Mfn2 gene deletion (9). In contrast to the point mu-
tations that accumulated with mitochondrial fragmentation
provoked by combined deletion of Mfn1 and Mfn2 in skeletal
muscle, we observed no increase in mtDNA point mutations
induced by cardiomyocyte-specific Mfn2 deficiency. We did,
however, detect an increase in double-stranded mtDNA
breaks manifested both as in–del mutations and linearized
genomes, which were associated with loss of cardiac mtDNA.
Because linearization of circular mtDNA has not previously
been described in cardiomyopathy and its functional impli-
cations were unknown, we conditionally expressed a mito-
chondrial-targeted single cutting DNA restriction enzyme
(XhoI) in Drosophila heart tubes. In the fruit fly heart, mtDNA
linearization decreased mtDNA content and caused cardio-
myopathy. These studies show that double-stranded mtDNA
breaks linearize a fraction of mitochondrial genomes that,
independent of mtDNA point or in–del mutations, can con-
tribute to end-organ dysfunction.
Results
mtDNA defects in Mfn2-deficient hearts
Mfn2 is the essential mitochondrial receptor for Parkin on
depolarized mitochondria (9, 26). Thus, Mfn2 deficiency
produced by cardiac-specific gene ablation interrupts a pro-
tective mitophagy pathway, and the resulting accumulation
of abnormal mitochondria impairs cardiomyocyte respiration
and induces a progressive cardiomyopathy by 16 weeks of
age (9). One of the molecular hallmarks of cardiomyopathy is
altered cardiac gene expression (17), but the genetic response
to interruption of Mfn2-facilitated cardiac mitophagy has not
been described. Accordingly, we used deep RNA sequencing
(28) to quantify expression of both nuclear- andmitochondrial-
encoded mRNAs before (i.e., in 6-week-old mice) and after
(i.e., in 16-week-old mice) onset of cardiomyopathy that de-
velops in Mfn2-deficient mouse hearts. Genome-wide tran-
scriptional profiling identified 7290 cardiac transcripts
expressed at levels of one mRNA copy per cell or greater (raw
sequence results were deposited at https://submit.ncbi
.nlm.nih.gov/subs/bioproject/, project number SRX285687).
Comparison of mRNA expression levels for 6 and 16 week
Mfn2-deficient mouse hearts to their respective age-matched
controls identified 1141 dysregulated (1.3-fold change from
control, false discovery rate [FDR] = 0.01) cardiac-expressed
mRNAs (Supplementary Table S1; Supplementary Data are
available online at www.liebertpub.com/ars). Unsupervised
hierarchical clustering of raw (Fig. 1A, left) or normalized
(Fig. 1A, right) mRNA expression levels perfectly segregated
control from Mfn2-deficient hearts. Sixteen-week-old Mfn2-
deficient hearts tended to cluster to the right of their 6-week-
old Mfn2 null counterparts, suggesting more severe mRNA
dysregulation. Indeed, the number of regulated mRNAs
changed more than 50%, 75%, or 100% was significantly
greater in 16 week than 6 week Mfn2 null hearts (Chi-square
p < 0.001 for each comparison). Thus, the transcriptional sig-
nature evoked by cardiomyocyte-specific Mfn2 deletion
precedes cardiomyopathy and is exaggerated with age. Gene-
ontology analysis revealed that a disproportionate number of
the dysregulated transcripts belong to functional categories
related to mitochondria or metabolism ( p< 0.05; Fig. 1B),
suggesting a primary effect of Mfn2 ablation on cardiac genes
involving cellular metabolism.
Mitochondria contain *800 nuclear-encoded and just 13
mitochondrial-encoded proteins (21). Of 766 nuclear-encoded
mitochondrial proteins listed in www.mitoproteome.org, we
detected 650 expressed at 1 mRNA copy per cell or greater in
mouse hearts. A disproportionate 28% (183/650; compared to
1141/7290, or 16% of total cardiac transcripts; p= 0.01) of
these cardiacmitochondrial protein encoding transcripts were
dysregulated in Mfn2-deficient hearts (Fig. 1C and Supple-
mentary Table S2). Modulated expression of mitochondrial
genes anticipated cardiomyopathy, as it was detected in
6-week-old Mfn2 null hearts.
Mitochondrial biogenesis is frequently described in heart
disease as reactive changes in the expression of genes that di-
rect mtDNA replication and transcription (20, 40). We exam-
ined the mRNA expression profile induced by cardiomyocyte
Innovation
Mitochondria are purportedly generated through bio-
genesis and undergo cyclic fusion and fission that main-
tains homeostasis until senescent or damaged organelles
are eliminated by mitophagy. Here, we unify these three
apparently distinct processes by describing a novel con-
sequence of interrupted mitophagy due to ablation of mi-
tofusin 2: mitochondrial DNA (mtDNA) linearization. We
prove that mtDNA linearization is sufficient to cause car-
diomyopathy in fruit flies. We propose that nuclear and
mitochondrial biogenic programs do not supply new or-
ganelles, but instead produce replacement components for
functioning mitochondria as they endlessly cycle between
organelle renewal via fusion and elimination of dysfunc-
tional components segregated via asymmetric fission.
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Mfn2 deficiency for regulated expression of mRNAs en-
coding factors central to mtDNA replication and RNA
transcription. Expression of several nuclear-encoded mito-
chondrial biogenesis genes was increased only in 16-week-
old Mfn2-deficient hearts (Fig. 2A). Remarkably, increased
expression of some mtDNA replication and transcription
factor genes concomitantly occurred with a precipitous de-
cline in the levels of mtDNA relative to nuclear DNA (Fig.
2B, left) and loss of cardiomyocyte mitochondrial nucleoids
(Fig. 2B, middle and right). We hypothesized that increased
expression of nuclear-encoded mitochondrial genes was an
attempt to compensate for the loss of mitochondrial ge-
nomes. Consistent with this notion, levels of the 13 mtDNA-
derived transcripts did not increase in parallel with their
nuclear-encoded mitochondrial protein counterparts,
pointing to a primary failure of mitochondrial gene tran-
scription (Fig. 2C). The loss of cardiac mtDNA content,
upregulation of some nuclear-encoded mitochondrial tran-
scription and replication factors, and absence of similar
upregulation of mitochondrial-derived transcripts reveal a
primary mtDNA defect in Mfn2-deficient hearts. A similar
decrease in mtDNA has been observed in Mfn1/Mfn2 dou-
ble knockout skeletal muscle (8). Since mitochondrial fu-
sion is impaired by combined Mfn1/Mfn2 ablation, but not
when Mfn2 is deleted alone, our findings suggest that the
mitochondrial genomic defects accrue from interruption of
Mfn2-Parkin-mediated mitophagy, and not abrogation of
mitochondrial fusion.
FIG. 1. Altered gene expression in Mfn2-deficient mouse hearts. (A) Heat map showing unsupervised nonhierarchical
clustering of regulated mRNA expression levels in 6- and 16-week-old wild-type (ctrl) and Myh6-Cre Mfn2 KO hearts. Each
column is a different mouse heart; each row is a different mRNA transcript. Left panel shows raw expression values, right panel
shows same expression data normalized for each mRNA. Blue is fewer copies/cell, and red is greater copies/cell. (B) Gene
Ontology classification of Mfn2-regulated mRNAs. (C) Unsupervised nonhierarchical clustering heat map of mRNA levels for
183 regulated mitochondrial genes. Left panel shows raw mRNA values, right panel is normalized data. Upregulated TFAM
and downregulated mfn2 (the KO gene) are indicated. Mfn, mitofusin; KO, knockout.
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Mitochondrial genomic rearrangements are caused
by cardiac Mfn2 ablation
Combined ablation of Mfn1 and Mfn2 in skeletal muscle is
postulated to induce skeletal myopathy in part by increasing
mtDNA point and in–del mutations (8). We assessed the in-
tegrity of mitochondrial genomes in Mfn2-deficient mouse
hearts by ultra-deep mtDNA resequencing. Because we esti-
mated that mouse myocardium contains *4000 mitochon-
drial genomes for each nuclear genome (Fig. 2B), to assure
adequate coverage for mutation detection we resequenced
myocardial mitochondrial genomes (Fig. 3A) at an average
depth of 101,035– 10,180 times per individual mouse heart.
There were no differences in the frequency of common or rare
single-nucleotide sequence variants between wild-type and
Mfn2 knockout hearts: mtDNA polymorphisms (defined as
variations from the reference sequence having a frequency of
1% or greater) were similar in wild-type and Mfn2-deficient
hearts, as expected since polymorphisms tend to be consistent
within a given mouse strain (2) (median 72 in wild-type, 66 in
FIG. 2. Mitochondrial gene expression and mtDNA abnormalities in Mfn2-deficient mouse hearts. (A) mRNA levels,
relative to same-age control, of nuclear-encoded mitochondrial transcription factors (left) and replication factors (right) taken
from RNA-Seq data in Figure 1. *, Significantly different than age-matched controls by group t-test; p-Values are given on
graphs. (B) Cardiomyocyte mitochondria lose mtDNA: (left) qPCR quantitation of mitochondrial-encoded ND2 gene indexed
to nuclear-encoded Pecam gene; n= 10 per group; (middle) merged confocal analysis of mitochondrial nucleoid content: left,
cardiomyocyte is from 16 week wild-type control and right, cardiomyocyte is from 16 weekMyh6-Cre Mfn2 KO. Red is mito-
tracker red, green is anti-dsDNA, nuclei are counterstained blue with DAPI. Mitochondrial nucleoids are visible as small
yellow/green punctae within red mitochondria. White scale bar is 20 lm. Quantitative data (n= 3 hearts per group) are to the
right. (C)mRNA levels of each of the 13 mitochondrial genome-encoded mitochondrial proteins are not changed in Mfn2 KO
hearts. mtDNA, mitochondrial DNA; qPCR, quantitative polymerase chain reaction.
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Mfn2-deficient, Mann–Whitney p= 0.15; Fig. 3B). We also
found no difference in the frequency or distribution of rare
mtDNAmutations, either within 966 bp of sequence defined as
mtDNA mutational hot spots (median 344 mutations in con-
trols, 350 in 6 weeks knockout (KO), and 323 in 16 weeks KO;
p= 0.82, Kruskal–Wallis test; Fig. 3C) or the remainingmtDNA
sequence (median 137 variants in controls, 98 in 6 weeks KO,
and 101 in 16 weeks KO; p= 0.92, Kruskal–Wallis test; Fig. 3D).
Single-nucleotide mutation frequency was similar within
mtDNA encoding proteins, ribosomal RNA (rRNA), tRNA,
and in the D-loop transcriptional control region (not shown).
mtDNA single nucleotide mutations are well tolerated,
even at high frequencies (37), and so their contribution to
mitochondrial dysfunction is likely small. By contrast, re-
gional mtDNA in–dels that remove critical portions of mito-
chondrial genes are an established cause of disease (34). We
therefore examined ourmtDNA sequence data for evidence of
in–dels, detectable as regional sequence copy number varia-
tions (CNV). In control hearts (6 and 16 week), sequence
depth was fairly constant across mtDNA regions (Fig. 4A and
Supplementary Fig. S1A). Sequence depth was also similar in
6-week-old Mfn2-deficient mtDNA, revealing no evidence of
CNV (Supplementary Fig. S1A). Remarkably, some mtDNA
sequences from 16-week-old Mfn2-deficient mouse hearts
revealed discrete areas where sequence depth was signifi-
cantly less (i.e., diverging more that two standard deviation
[SD]) than the mean control depth, identifying discrete ge-
nomic deletions (29) (Fig. 4A and Supplementary Fig. S1B–D).
We confirmed that mtDNA deletions occurred only in 16-
week-old Mfn2-deficient hearts in an independent cohort of
samples analyzed by flanking polymerase chain reaction
(PCR) analyses (Fig. 4B).
FIG. 3. Cardiac Mfn2 deficiency is not associated with increased myocardial single-nucleotide mtDNA sequence vari-
ations. (A) Schematic representation of murine mitochondrial genome. Mitochondrial-encoded genes are shown as arrows
showing direction of transcription; tRNAs are indicated by their single letter amino acid coding. (B) Frequency and position
of common polymorphic (allele freq > 0.01) nucleotide variations in pooled 6 week (n = 4) and 16 week controls (n = 3), 6 week
Mfn2 KO (n= 3), 16 week Mfn2 KO (n = 3) hearts. (C) Prevalence and position of rare variants in mutational ‘‘hot spots,’’ that
is, positions where mutations were detected in half of the same sequenced samples. (D) Frequency and position of rare
mutations outside of mutational hot spots in the same samples as (C). The distribution of mutations among protein-coding
genes, tRNAs, rRNAs, and the D-loop control sequence was the same between genotypes. tRNA, transfer RNA; rRNA,
ribosomal RNA.
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Linear mitochondrial genomes accumulate
in cardiac Mfn2 deficiency
A specific mtDNA deletion can cause disease when it de-
letes a critical portion of an encoded mtRNA, and when it is
maternally transmitted and therefore ubiquitous throughout
the organism (34). This cannot be the case with the mtDNA
deletions we detected in Mfn2-deficient hearts as the causa-
tive cardiomyocyte-specific genetic intervention (mfn2 gene
ablation) spares the germ cells, and the mtDNA deletions we
detected accumulate over time. Further, as revealed by the
mtDNA sequence data, deletions appeared stochastically at
multiple sites across the mitochondrial genomes, including
within a single heart. Thus, these mtDNA in–del mutations
almost certainly exhibit marked heteroplasmy, that is, a
mixture of mutant and normal mitochondria within the same
cell, and cannot explain the marked mitochondrial abnor-
malities observed in Mfn2-deficient mouse hearts (23). Ac-
cordingly, we looked for another explanation.
We considered that genomic mtDNA deletions require at
least two distinct breaks in the circular double-stranded
mtDNA (to delete part of the genome), followed by mtDNA
re-circularization and strand repair. By this reasoning, line-
arization of mtDNA (the inevitable consequence of a single
double-strand DNA break) is an absolute precondition for
forming in–del mtDNA mutations. The effects of mtDNA
linearization have not been studied in metazoan mitochon-
drial dysfunction. In yeast (which have branched linear mi-
tochondrial genomes), double-stranded breaks are either
repaired or the damaged genomes are cleared (19, 27). A
similar quality control mechanism likely repairs or eliminates
linear metazoan mtDNA. Since mtDNA linearization is a
prerequisite formtDNAdeletions, their accumulation in older
Mfn2-deficient hearts (vide supra) and Mfn1/Mfn2 double
knockout skeletal muscle (8) links the putative mtDNA
quality control mechanism to Mfn2-mediated mitochondrial
culling.
We developed a gel electrophoresis/mtDNA-specific
southern blot procedure to detect linear mtDNA in in vivo
heart samples. First, we demonstrated that electrophoresis of
intact andXhoI-treatedmousemtDNA (XhoI cutsmtDNA at a
single site, thus linearizing it) on 0.5% agarose gels for 20 h at
60V separates linear from intact circular mtDNA; linear
mtDNA migrates faster (Fig. 4C). We then adapted this
southern blotting approach to total DNA (i.e., combined mi-
tochondrial and nuclear DNA) extracted from mouse myo-
cardium. LinearmtDNA from heart samples co-migrates with
XhoI-cut mtDNA, and was detected in 16-week-old, but not
FIG. 4. Accumulation of mtDNA double-strand breaks in Mfn2-deficient hearts. (A) Sequence depth for mtDNA se-
quencing, depicted by nucleotide position across the mitochondrial genome, for the mean of all 16 week control hearts (black)
and one of three 16 week Mfn2 KO hearts (red). Mitochondrial-encoded genes from Figure 3A are shown in their relative
position along the horizontal axis. Arrowheads at top indicate two regions of CNV in the 16 week Mfn2 KO sequence.
Horizontal arrows at the bottom show positions of PCR primers used for amplifying across CNV in (B). Other mtDNA
sequence data are depicted in Supplementary Figure S1. (B) Accumulation of regional mtDNA deletions in older Mfn2 KO
hearts. PCR primers that span mitochondrial genome CNVs detected by sequencing (A) were used for 12 additional inde-
pendent cardiac mtDNA samples. mtDNA deletions (arrows) were detected in all three 16 week Mfn2 KO hearts. (C) Linear
mitochondrial genomes are detected in older Mfn2 KO hearts. Southern blotting of XhoI-linearized mitochondrial-specific
mouse heart DNA. (D) Representative (of four per group) Southern blot analysis of mtDNA. Linear genomes are indicated
with arrowheads. XhoI-cut mouse cardiac mtDNA is shown on the right (Ctrl). Intact circular mtDNA is not visualized, but
equal DNA loading is shown by the faster-migrating nonspecific DNA signals. CNV, copy number variation; PCR, poly-
merase chain reaction.
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6-week-old, Mfn2-deficient hearts or control hearts (Fig. 4D,
right; arrowheads). Because the experimental samples used
whole heart (mixed nuclear and mitochondrial) DNA and we
took precautions not to physically damage mtDNA by
shearing, intact circular mtDNA is not visualized in the
myocardial samples. It is therefore not possible to quantify the
proportion of mtDNA that is linear versus nonlinear from
this experiment. Nevertheless, the high concordance between
heart samples with evidence for mtDNA linearization and
mtDNA in–del mutations shows that a consequence of car-
diac Mfn2 deficiency is accumulation of mtDNAwith double-
stranded breaks.
mtDNA linearization is sufficient to cause
mitochondrial cardiomyopathy
The consequences of mtDNA linearization on cardiac ho-
meostasis are unknown. Since we did not detect either mtDNA
deletion mutations or linear mtDNA in normal hearts, we
considered that normal mtDNA repair mechanisms efficiently
re-circularize the linearized mitochondrial genomes or selec-
tively eliminate them, with few cumulative adverse effects.
However, the putative mtDNA re-circularization and repair
mechanismsmay be overwhelmed andmitochondrial integrity
compromised when mtDNA damage is severe and/or normal
mitophagic clearancemechanisms are suppressed. To test these
possibilities we developed Drosophila models conditionally ex-
pressing mitochondrial-targeted XhoI in cardiomyocytes (Mi-
toXhoI). As with mouse mtDNA (Fig. 4C), XhoI cleaves
Drosophila mtDNA at a single site (in the cytochrome oxidase
subunit 1 gene) (38), linearizing mtDNA without deleting any
of the mitochondrial genome. Expression of pUAS-MitoXhoI
using a conventional cardiomyocyte-specific tincD4Gal4 driver
(Fig. 5A, left) resulted in almost universal lethality during the
second and third instar larval stages and early after pupation.
Twoescapers that emerged as adults showed severely impaired
cardiac function assessed by optical coherence tomography
(OCT) (Fig. 5A, right), and these flies almost immediately suc-
cumbed. Thus, cardiomyocyte-specific MitoXhoI expression
established that linear mtDNA is incompatible with normal
FIG. 5. mtDNA linearization with MitoXhoI induces cardiomyopathy in Drosophila. (A) (left) Schematic depiction of
conventional TincD4-Gal4/pUAS system for cardiac-specific expression of MitoXhoI in Drosophila that was > 99% lethal
before emergence as adults. (right) OCT of a control (Ctrl) and one of two adult cardiac MitoXhoI flies; heart tube function is
severely depressed in the MitoXhoI fly. (B) (left) Schematic diagram of temperature inducible system for transient, conditional
expression of MitoXhoI in fly cardiomyocytes. (right) Representative OCT of control and conditional MitoXhoI heart tubes 1
week (top) and 2 weeks (bottom) after induction. (C) Group mean data (SEM) for OCT FS at 1 week (n = 13/group) and 2
weeks (n = 6–8/group) after transient (3 day) MitoXhoI induction. (D) Merged confocal analysis of mitochondrial nucleoid
content: left, Drosophila heart tube is from 1 week control and right, heart tube is from 1 week after transient cardiac-specific
MitoXhoI expression. Red is mito-tracker red, green is anti-DNA, nuclei are counterstained blue with DAPI. Mitochondrial
nucleoids are visible as small yellow/green punctae within red mitochondria. White scale bar is 50lm. Quantitative data
(n = 3 fly tubes/group) are on the right. FS, fractional shortening; OCT, optical coherence tomography.
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heart development and function, but early lethality precluded a
more detailed characterization of cardiac phenotypes.
To better understand the time-dependent consequences of
cardiomyocyte mtDNA linearization we employed a condi-
tional Gal80ts system (Fig. 5B, left) to induce MitoXhoI in the
heart tubes of adult flies. Flies were bred and allowed to de-
velop through the pupal stage at 19C, which does not permit
MitoXhoI expression. Newly emerged adults were moved to
the expression-permissive temperature of 29C for 3 days,
which induced cardiomyocyte transgene expression as mea-
sured by an enhanced green fluorescent protein (eGFP) mar-
ker driven by the same tincD4Gal4/Gal80ts system. Oneweek
after MitoXhoI induction, Drosophila heart tubes exhibited
reduced contractility, measured as decreased fractional
shortening (%FS), compared with identically treated controls
(Fig. 5B, right, C). This is the fruit fly analog of dilated car-
diomyopathy (16). To determine the capacity of fruit fly heart
tubes to recover from mtDNA linearization by XhoI we
studied a separate cohort of flies 2 weeks after MitoXho1 in-
duction. Because these flies were placed at the normal main-
tenance temperature of 23C after 3 days at the permissive
temperature of 29C, they had 10 days to repair or eliminate
the damaged mitochondrial genomes and recover cardiac
function. Yet, we observed no functional recovery during this
period (Fig. 5C). Cardiomyocyte mtDNA was quantified by
confocal analysis of mitochondrial nucleoids, and it was
markedly decreased by XhoI expression (Fig. 5D). Together,
these results indicate that double-strand breaks of mtDNA
such as those induced by XhoI-mediated linearization are
persistent, are sufficient to deplete cardiomyocyte mtDNA,
and will lead to cardiomyopathy.
Discussion
Here, in studies of mouse hearts, Drosophila heart tubes,
and mitochondrial genomes, we detected double-stranded
mtDNA breaks after interrupting Mfn2-dependent cardiac
mitochondrial quality control. We further demonstrated that
mtDNA linearization is sufficient to cause cardiomyopathy.
These results reveal deleterious effects of mitochondrial ge-
nome linearization, and not just in–del mutations, on mito-
chondrial homeostasis in the heart.
We tend to conceive of mitochondria as having a life cycle;
new mitochondria are formed via ‘‘biogenesis’’ (21), they
function for a period of time, and then they become senescent,
manifested as depolarization and increased production of
toxic reactive oxygen species (ROS) (3). Because senescent
mitochondria are cytotoxic, fission/fusion and mitophagy
mechanisms have evolved to eliminate them. Dysfunctional
mitochondria sequester damaged components into one of two
daughter mitochondria formed via assymetrical organelle
fission; the defective daughter mitochondrion is then selec-
tively eliminated via mitophagy, whereas the more normal
daughter mitochondrion is reintroduced into the cell popu-
lation via fusion (35). Thus, mitochondrial dynamics and mi-
tochondrial quality control are inextricably related. The
current results add the genetic program for producing new
mitochondrial proteins, or ‘‘mitochondrial biogenesis’’ into
this schema, supporting functional integration of mitochon-
drial dynamics, biogenesis, and quality control.
mtDNA mutations have been implicated in myopathic
phenotypes in the ‘‘mito-mutator mouse,’’ which expresses a
proofreading defective mtDNA polymerase (14), and after
combined skeletal muscle ablation of Mfn1 and Mfn2 (8).
Using ultra-deep resequencing of mtDNA we did not find
evidence that increased mtDNA single-nucleotide mutations
contribute to the cardiomyopathy caused by cardiac Mfn2
deletion. We believe that lack of causality of single nucleotide
variants in the current study is consistent with a number of
prior observations: First, mitochondrial mutations in themito-
mutator and skeletal muscle Mfn1/Mfn2 double knockout
mice were associated with mitochondrial respiratory com-
promise and/or dissipation of mitochondrial inner mem-
brane potential, which were not induced by cardiac Mfn2
deficiency (9, 10). Second, mitochondrial mutations in genes
encoding OXPHOS proteins or tRNAs in the mito-mutator
mouse undergo trans-generational clonal expansion to pro-
duce mitochondrial respiratory dysfunction and increased
ROS (1). Because we ablated mfn2 in cardiac myocytes after
embryonic development, mtDNA heritability can play no role
in our studies. Third, although mtDNA has a mutation rate
10–20 times higher than nuclear DNA (attributed to absence
of protective histones and limited repair mechanisms) (4), the
vast majority of mtDNA mutations are functionally recessive
(34). Thus, 60%–90% of mtDNAs in heteroplasmic cells can
harbor mutations before mitochondrial respiration dysfunc-
tion is observed (13, 32).
Mitochondrial abnormalities induced by interruption of
PINK1-Parkin signaling after postnatal cardiomyocyte-
specific Mfn2 deletion include increased mitochondrial size (9)
and a decline in mtDNA content. The progressive cardiomy-
opathy of Mfn2 deficiency is therefore linked to replacement
of normal mitochondria with larger mitochondria having
fewer mitochondrial genomes. The *16.6 kb mitochondrial
genome encodes 13 mitochondrial proteins in addition to 22
tRNAs and 2 rRNAs. Transcription of mitochondrial-encoded
RNAs is bidirectional on the heavy and light mtDNA chains,
and would be interrupted by the double-stranded DNA
breaks that we identified. Although in–dels in mtDNA repair
the circular genome structure and therefore permit tran-
scription and replication, linearization of mtDNA likely rep-
resents a functional dead-end, interrupting mitochondrial
replication, which is a critical mitochondrial component of
mitochondrial biogenesis (25). We observed that the nuclear
mitochondrial biogenesis program increased in apparent
compensation.
An individual mitochondrion typically has several copies of
its genome packaged as discreet nucleoprotein complexes, or
nucleoids, which can be exchanged between fused mitochon-
dria in a form of genetic complementation (30). Mitochondrial
fusion mediated by Mfn1, Mfn2, and Opa1 also facilitates
exchange of mitochondrial gene products, that is, mtDNA-
encoded proteins, tRNAs, and rRNAs.Mixing ofmitochondrial
inner and outer membranes, nuclear- and mitochondrial-
encoded respiratory enzymes, translational and transcriptional
machinery, and other matrix components between fused
mitochondria temporarily compensates for perturbations of
defective genomes, renewing mitochondrial respiratory func-
tion. Mitochondria that are excessively damaged, including
those with defective genomes, do not undergo fusion-
dependent functional complementation and instead are tar-
geted for elimination through the process of mitophagy.
In the context of Mfn2 acting as a critical mediator of
PINK1-Parkin signaling and a mitochondrial fusion factor (9,
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26, 31, 33), and the current observation that mtDNA levels
plummet in Mfn2-deficient cardiomyopathic hearts, we have
re-evaluated our concept of a mitochondrial life cycle. As the
descendents of primordial bacteria that developed endo-
symbiotic relationships with ancestral unicellular organisms,
we believe that mitochondria have no life cycle per se; like the
bacteria from which they descended, mitochondria are im-
mortal. Since there are no ‘‘newborn’’ mitochondria, what is
the function of the gene expression program we describe as
mitochondrial biogenesis? We propose that nuclear and mi-
tochondrial biogenic programs do not supply new organelles,
but instead produce replacement components for functioning
mitochondria as they endlessly cycle between renewal and
senescence. The current studies indicate that Mfn2, acting as
the transducer of PINK1-Parkinmitophagy signaling, helps to
maintain the integrity of mitochondrial renewal by prevent-
ing accumulation of mtDNA with double-stranded breaks.
We further demonstrate that mtDNA linearization is suffi-
cient to cause the type of cardiomyopathies that are observed
in mice and flies when PINK1-Mfn2-Parkin-mediated mito-
phagy is interrupted (9). We suggest that linearized mtDNA
deserves evaluation as a potential contributing factor in other
diseases, like Parkinson’s and Alzheimer’s disease, in which
defects in mitochondrial quality control apparati can be
causative.
Materials and Methods
Mouse generation and phenotypic analyses
Mfn2loxp/loxp mice (6, 7) were obtained from University of
California-Davis and crossed onto theMyh6-nuclear-directed
‘‘turbo’’ Cre line (36) for cardiomyocyte-specific gene deletion
after birth. The cardiac phenotype of thesemicewas described
previously (9, 10). All experimental procedures were ap-
proved by the Animal Studies Committee at Washington
University School of Medicine.
Transcriptional profiling by deep mRNA sequencing
of mouse hearts
Transcriptional profiling of Mfn2-KO cardiac tissues was
performed by deep mRNA sequencing as described (28). Heat
mapping of expression data and statistical analysis used Partek
Genomics Suite version 6.4 (Parteko). Original RNA sequence
data have been deposited at https://submit.ncbi.nlm.nih.gov/
subs/bioproject/, project number SRX285687.
Mouse mitochondrial genomics analyses
Ultra-deep mtDNA sequencing started with isolated car-
diac mitochondria. mtDNA was purified using phenol/
chloroform extraction and ethanol precipitation. For each
heart, 50–100 ng of mtDNA was randomly fragmented by
sonication (Diagenode Bioruptor XL). Following column pu-
rification (Qiaquick; Qiagen) Illumina sequencing libraries
were generated as previously described (28) and single-end
sequenced on an Illumina HiSeq. Raw sequence reads (42 nt
per read at an average of 67.3 million reads, with 65.3%
alignment to the mitochondrial genome) were aligned to the
C57BL6/J mitochondrial genome (GenBank: EF108336.1) us-
ing Bowtie package version 0.12.7 (24), allowing up to three
mismatched nucleotides per read while stipulating that each
read align to one genomic position only. VarScan version 2.2.3
(22) was used to calculate coverage depth and call variants
from aligned reads, using minimum Illumina nucleotide
quality scores of 32. The average coverage depth was
> 100,000; the lowest coverage depth among the mtDNA
samples *40,000, in which a single sequence variant in a
single read would be observed at frequency of 0.000025.
Thirty reads were nominated as a minimum for a confident
call, resulting in a minimum detectable frequency of 0.00075
that was used for analysis of all samples. Variants that were
not observed on both DNA strands were censored (*4% of
observed variation). Original mtDNA sequence data have
been deposited at https://submit.ncbi.nlm.nih.gov/subs/
bioproject/, project number SRX285809.
To compare the amounts of mtDNA and nuclear DNA, we
used quantitative PCR (11). Relative copy number differences
are expressed as the difference in amplification cycle thresh-
old, C(t), between mtDNA and nuclear DNA assays (DC(t)
method).
To detect regional deletions in mtDNA, we designed PCR
primers to span regions of CNV detected by mtDNA se-
quencing. Thermopol Taq DNA polymerase system was used
for PCR (94C 30 s, 60C 30 s, 72C 1.5min): Primer pair 1;
forward, 5¢ gccaatgaaatgggaagaaa; reverse, 5¢ atgccgtatggac
caacaat (amplifies mtDNA nucleotide 761–2884). Primer
pair 2; forward, 5¢ ggcctcacatcatcactcct, reverse, 5¢ ctcgtccga
catgaaggaat (amplifies mtDNA nucleotide 13163–14720). Pri-
mer pair 3 (negative control); forward, 5¢ accagcattccagtcctcac,
reverse, 5¢ tagggccgcgataataaatg (amplifies mtDNA nucleotide
9410–11457).
Linearization of mtDNAwas detected by mtDNA -specific
southern blotting of total cardiac DNA (2mg) after size-
separation on 0.5% agarose gels (20 h at 60V). Intact and
XhoI-digested mouse mtDNA were run as controls.
Mitochondrial nucleoids were visualized in isolated mu-
rine cardiomyocytes or Drosophila heart tubes by merged
confocal microscopy of mitochondria (MitoTracker Red) and
DNA (anti-dsDNA, #ab27156; Abcam) and quantified using
ImageJ.
Drosophila lines and cardiac analyses
Drosophila melanogaster tub-Gal80ts; tinCD4-Gal4 (obtained
from Rolf Bodmer, Sanford-Burnham Medical Research In-
stitute) were crossed to UASp-MitoXhoI 2.1/CyO (provided
by Patrick O’Farrell, UCSF) to generate F1 progeny with
temperature-inducible cardiomyocyte-specific expression of
MitoXhoI. Parental crosses were maintained at 19C, which
does not permit transgene expression. Emerging F1 progeny
were collected each day and incubated at 29C for 3 days for
transgene induction, and then shifted to room temperature for
maintenance (22–23C). Expression characteristics of the tub-
Gal80ts; tinCD4-Gal4 system as a function of these tempera-
tures were monitored with UASp-eGFP (Bloomington stock
#6874). Heart tube contraction was assessed using OCT as
described (16, 18) at room temperature on 7- and 14-day-old
flies. Control crosses were set up with w1118 (Bloomington
stock #6326).
Statistical methods
Data are presented as mean – SEM, except for average
mtDNA sequence depth that is depicted as mean – SD. Paired
comparisons between Mfn2-deficient hearts and their age-
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matched controls used Student’s t-test. Multiple comparisons
for mtDNA mutation analyses, in which 6 and 16 week con-
trols were pooled, used one-way ANOVA and Newman–
Keuls test, or Kruskal–Wallis tests for nonparametric data.
Differences in data distribution were examined using Chi-
square test. Statistical difference was defined as p < 0.05.
RNA-sequence expression data were analyzed at an FDR of
0.01; p-values comparing expression levels of all *1100 reg-
ulated mRNAs in 6- and 16-week-old Mfn2-deficient hearts
to their age-matched controls are in Supplementary Table S1.
GOcategory assignment andover-representationusedBiNGO.
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CNV¼ copy number variation
eGFP¼ enhanced green fluorescent protein





OCT¼ optical coherence tomography
PCR¼polymerase chain reaction
PINK1¼PTEN-induced putative kinase 1
rRNA¼ ribosomal RNA
ROS¼ reactive oxygen species
SD¼ standard deviation
tRNA¼ transfer RNA
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